Utah House Passes Bills to Restrict Transgender Care for Minors

Legislation aims to ban hormone treatments and limit insurance coverage for gender-affirming care

Feb. 5, 2026 at 9:15pm

Got story updates? Submit your updates here. ›

The Utah House of Representatives has passed three bills that would significantly restrict access to gender-affirming care for transgender individuals, particularly minors. The first bill would turn the state's current moratorium on newly prescribed hormonal treatments for under-18s into a full ban, requiring doctors to stop writing prescriptions by 2027. The second bill would prevent publicly-funded Utah employers from offering insurance coverage for transgender surgical procedures or hormonal treatments. The third bill would require private insurers that cover transgender care to also cover 'detransition' procedures and treatments.

Why it matters

These bills are part of a broader trend of legislation targeting transgender people, particularly transgender youth, across the United States. Advocates argue the bills will have a devastating impact on a vulnerable population, putting their health and safety at risk. Critics of the bills say they are not based on sound scientific evidence and represent government overreach into personal medical decisions.

The details

The first bill, HB174, would turn Utah's 2023 moratorium on newly prescribed hormonal transgender treatments for minors into a full ban. It passed the House 54-16, despite objections from Democrats that the arguments in support of the bill were not supported by good science. The second bill, HB193, would restrict publicly-funded Utah employers from offering insurance coverage for transgender surgical procedures or hormonal treatments. It passed 48-21. The third bill, HB258, would require private insurers that cover transgender care to also cover 'detransition' procedures and treatments. It passed 53-16.

  • The current moratorium on newly prescribed hormonal transgender treatments for minors in Utah was enacted in 2023.
  • HB174 would require Utah doctors for teenagers currently undergoing treatments to stop writing prescriptions by January 28, 2027.

The players

Rep. Rex Shipp

The Republican sponsor of HB174, which would turn Utah's moratorium on hormonal transgender treatments for minors into a full ban.

Rep. Jennifer Dailey-Provost

A Democratic representative who argued the data used to support HB174 was flawed and that "denying health care to a very marginalized, at-risk population of children is always going to be a mistake."

Catherine Dillon

A mother of a 16-year-old transgender daughter who is currently undergoing hormonal treatments and argued the bill would "harm her" and "push care underground, out of state and out of reach."

Rep. Nicholeen Peck

The Republican sponsor of HB193, which would restrict publicly-funded Utah employers from offering insurance coverage for transgender care, and HB258, which would require private insurers to cover 'detransition' procedures.

Rep. Sahara Hayes

A Democratic representative who argued HB193 was "singling people out" and that "one person's elective is somebody else's medically necessary."

Got photos? Submit your photos here. ›

What they’re saying

“Denying health care to a very marginalized, at-risk population of children is always going to be a mistake.”

— Rep. Jennifer Dailey-Provost, Democratic Representative

“This bill does not protect children. … This bill only pushes care underground, out of state and out of reach.”

— Catherine Dillon, Mother of Transgender Daughter

“This bill is singling people out. One person's elective is somebody else's medically necessary, and that is a distinction that should be made between the patient and their doctor. Not 104 legislators in the exam room with them.”

— Rep. Sahara Hayes, Democratic Representative

What’s next

The three bills now advance to the Utah Senate for further consideration.

The takeaway

These bills represent the latest efforts by conservative state legislatures to restrict access to gender-affirming healthcare, particularly for transgender youth. Advocates warn the legislation will have a devastating impact on a vulnerable population and interfere with personal medical decisions, while supporters argue the treatments are too risky for minors to consent to. The debate highlights the ongoing political and social tensions surrounding transgender rights in the United States.